These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26276791)

  • 1. Apelin and Visfatin Plasma Levels in Healthy Individuals With High Normal Blood Pressure.
    Liakos CI; Sanidas EA; Perrea DN; Grassos CA; Chantziara V; Viniou NA; Barbetseas JD; Papadopoulos DP
    Am J Hypertens; 2016 May; 29(5):549-52. PubMed ID: 26276791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipokines: a novel link between adiposity and carotid plaque vulnerability.
    Kadoglou NP; Sailer N; Moumtzouoglou A; Kapelouzou A; Gerasimidis T; Kostakis A; Liapis CD
    Eur J Clin Invest; 2012 Dec; 42(12):1278-86. PubMed ID: 23033969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of atorvastatin on apelin, visfatin (nampt), ghrelin and early carotid atherosclerosis in patients with type 2 diabetes.
    Kadoglou NP; Sailer N; Kapelouzou A; Lampropoulos S; Vitta I; Kostakis A; Liapis CD
    Acta Diabetol; 2012 Aug; 49(4):269-76. PubMed ID: 21748474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of antihypertensive treatment on plasma apelin, resistin, and visfatin concentrations.
    Skoczylas A; Piecha G; Więcek A
    Pol Arch Med Wewn; 2016 Apr; 126(4):243-53. PubMed ID: 27129086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects.
    Li L; Yang G; Li Q; Tang Y; Yang M; Yang H; Li K
    Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):544-8. PubMed ID: 17177135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visfatin and apelin, new adipocytokines, and their relation to endothelial function in patients with chronic renal failure.
    Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
    Adv Med Sci; 2008; 53(1):32-6. PubMed ID: 18635422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus.
    Kadoglou NP; Tsanikidis H; Kapelouzou A; Vrabas I; Vitta I; Karayannacos PE; Liapis CD; Sailer N
    Metabolism; 2010 Mar; 59(3):373-9. PubMed ID: 19815243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal and cord blood apelin, resistin and visfatin levels in gestational diabetes mellitus.
    Oncul M; Tuten A; Erman H; Gelisgen R; Benian A; Uzun H
    Minerva Med; 2013 Oct; 104(5):527-35. PubMed ID: 24101110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of circulating adipocytokines vaspin, apelin, and visfatin in the loss of appetite in underweight children: a pilot trial.
    Vehapoglu A; Ustabas F; Ozgen TI; Terzioglu S; Cermik BB; Ozen OF
    J Pediatr Endocrinol Metab; 2015 Sep; 28(9-10):1065-71. PubMed ID: 25915077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apelin, vaspin, visfatin and adiponectin in large for gestational age infants with insulin resistance.
    Cekmez F; Canpolat FE; Pirgon O; Çetinkaya M; Aydinoz S; Suleymanoglu S; Ipcioglu OM; Sarici SU
    Cytokine; 2011 Nov; 56(2):387-91. PubMed ID: 21742512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum oxidative stress, visfatin and apelin in healthy women and those with premenstrual syndrome.
    Incebiyik A; Camuzcuoglu A; Hilali NG; Ulas T; Vural M; Camuzcuoglu H; Aksoy N
    J Obstet Gynaecol; 2015 Feb; 35(2):188-92. PubMed ID: 25110962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute and chronic effects of biliopancreatic diversion with duodenal switch surgery on plasma visfatin and apelin levels in patients with severe obesity.
    Caron-Cantin SM; Martin J; Bastien M; Munkonda MN; Lu H; Cianflone K; Moustarah F; Biertho L; Marceau S; Hould FS; Bussières J; Poirier P
    Obes Surg; 2013 Nov; 23(11):1806-14. PubMed ID: 23585024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visfatin may be a novel marker for identifying stages of essential hypertension in advanced age patients.
    Gunes F; Akbal E; Cakir E; Akyurek O; Altunbas M; Ozbek M
    Intern Med; 2012; 51(6):553-7. PubMed ID: 22449661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of novel adipokines in patients with acute ischemic stroke: potential contribution to diagnosis and prognosis.
    Kadoglou NP; Fotiadis G; Lambadiari V; Maratou E; Dimitriadis G; Liapis CD
    Peptides; 2014 Jul; 57():12-6. PubMed ID: 24768795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in plasma apelin and visfatin levels between patients with type 1 diabetes mellitus and healthy subjects and response after acute hyperglycemia and insulin administration.
    Alexiadou K; Kokkinos A; Liatis S; Perrea D; Katsilambros N; Tentolouris N
    Hormones (Athens); 2012; 11(4):444-50. PubMed ID: 23422767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma visfatin/nicotinamide phosphoribosyltransferase levels in hypertensive elderly - results from the PolSenior substudy.
    Kocelak P; Olszanecka-Glinianowicz M; Owczarek A; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Zdrojewski T; Grodzicki T; Więcek A; Chudek J
    J Am Soc Hypertens; 2015 Jan; 9(1):1-8. PubMed ID: 25537462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active visfatin is elevated in serum of maintenance haemodialysis patients and correlates inversely with circulating HDL cholesterol.
    Nüsken KD; Petrasch M; Rauh M; Stöhr W; Nüsken E; Schneider H; Dötsch J
    Nephrol Dial Transplant; 2009 Sep; 24(9):2832-8. PubMed ID: 19389865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasma visfatin concentration is a marker of an atherogenic metabolic profile.
    Filippatos TD; Tsimihodimos V; Derdemezis CS; Gazi IF; Saougos V; Mikhailidis DP; Tselepis AD; Elisaf MS
    Nutr Metab Cardiovasc Dis; 2013 Apr; 23(4):330-6. PubMed ID: 21963513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apelin: a peptide involved in cardiovascular risk in hemodialysis patients?
    Leal VO; Lobo JC; Stockler-Pinto MB; Farage NE; Calixto A; Geloneze B; Mafra D
    Ren Fail; 2012; 34(5):577-81. PubMed ID: 22417287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between plasma visfatin levels and ED.
    Karataş ÖF; Yıldırım ME; Celik HT; Badem H; Çaviş M; Çimentepe E
    Int J Impot Res; 2015 Jul; 27(4):157-60. PubMed ID: 25693971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.